If you’re considering medication for weight management, you may have heard that tirzepatide leads to more weight loss than semaglutide. In a study comparing the two injections directly, that was true on average. But an average can’t tell you which medication fits your health history, what side effects you might experience, or whether you’ll be able to continue treatment. Those questions matter just as much when you’re making a decision. New England Journal of Medicine
Semaglutide and tirzepatide are the names of the active ingredients. Wegovy is a brand of semaglutide approved for weight management, and Zepbound is a brand of tirzepatide approved for that purpose. Both can help eligible adults lose weight and maintain that loss alongside changes in eating habits and physical activity. They’re options for adults with obesity, or adults with overweight who also have a weight-related health condition. novo-pi.com
The main difference is how they interact with the signals your body uses around mealtimes. Semaglutide activates a receptor called GLP-1, which helps regulate appetite and blood sugar. Tirzepatide activates GLP-1 and a second receptor called GIP. With either medication, you may notice that you feel full earlier in a meal. Acting on two receptors doesn’t mean tirzepatide is twice as effective, and the two medications should not be taken together. novo-pi.com
The SURMOUNT-5 trial compared weekly injections in 751 adults with obesity who did not have type 2 diabetes. After 72 weeks, participants taking tirzepatide had lost an average of 20.2% of their starting weight, compared with 13.7% for participants taking semaglutide. The study compared the highest doses participants could tolerate within its protocol: 10 or 15 mg of tirzepatide and 1.7 or 2.4 mg of semaglutide. New England Journal of Medicine
Those numbers help answer a specific question: which injection produced more weight loss, on average, at the doses studied? They don’t predict your result, compare every available dose or formulation, or tell us what someone with type 2 diabetes should expect. They also leave out something you’ll notice long before week 72: how you feel on the medication day to day. New England Journal of Medicine
Your health history can give your prescriber a reason to discuss one option first. For example, Wegovy has an approved use to reduce the risk of major cardiovascular events in adults who already have cardiovascular disease and have overweight or obesity. Zepbound has an approved use for moderate to severe obstructive sleep apnea in adults with obesity. If either condition is part of your history, mention it at your consultation. It can make the conversation more useful than simply asking which medication leads to the most weight loss. novo-pi.com
Your routine matters, too. The trial compared two weekly injections, but Wegovy also comes in a tablet form. If you’d prefer an oral medication, ask your prescriber about that product specifically rather than assuming the injection study’s results apply to the tablet. And before starting either medication, ask what your insurance covers, what you would pay each month, and what follow-up visits would involve. These treatments are intended for long-term weight management, so it helps to understand the ongoing commitment from the start. novo-pi.com
Both medications can cause nausea, vomiting, diarrhea, or constipation. In the head-to-head trial, digestive side effects were most common while doses were increasing. Tell your prescriber if symptoms are interfering with meals or making it hard to stay hydrated. Severe abdominal pain that does not go away, especially if it spreads to your back, needs prompt medical attention because it can be a sign of pancreatitis. New England Journal of Medicine
Before treatment, tell your provider about your medications and medical history. Neither medication should be used if you or a family member has had medullary thyroid carcinoma, or if you have multiple endocrine neoplasia type 2 (MEN 2). If you use insulin or another diabetes medication that can lower blood sugar, your prescriber may need to adjust your plan. novo-pi.com
One difference that’s easy to miss: tirzepatide can make birth control pills less effective. Its prescribing information recommends switching to a non-oral contraceptive or adding a barrier method for four weeks after starting and for four weeks after each dose increase. Neither medication should be used for weight loss during pregnancy. If you’re planning a pregnancy, bring it up before starting treatment; semaglutide should be stopped at least two months before a planned pregnancy. pi.lilly.com
You don’t have to walk in already knowing which medication you want. Bring a list of what you take, what you’ve tried before, and what you hope treatment would change in your daily life. A useful first question is: “Given my health history, why would you recommend one option over the other?” Then ask how you’ll track progress together, who to contact if you feel unwell, and what the plan would be if your coverage or goals change.
If you’d like to talk through your options in English or Spanish, book a consultation with KYA IV & Aesthetics in Denver. Podemos platicar con calma sobre tus metas, tus dudas y si alguno de estos tratamientos tiene sentido para ti.
